It is noteworthy that all four groups of bone marrow recipients displayed similar hypercholesterolemia, thus documenting that the differences in atheroprotection were not due to differences in plasma lipoprotein clearance in ApoE−/− mice. This evidence concerns the gene APOE and familial hypercholesterolemia.